• Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

  • Oct 17 2024
  • Length: 3 mins
  • Podcast

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Listen for free

View show details

  • Summary

  • Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

    Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

    See omnystudio.com/listener for privacy information.
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available